RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Birmingham, AL · +73 more sites
Obesity clinical trials in Birmingham, AL
21 recruiting obesity studies with a site in Birmingham, AL.
RecruitingNot applicableNCT05124808
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Sponsor: Indiana University
Birmingham, AL · +4 more sites
RecruitingPhase 2NCT07837973
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Sponsor: Alveus Therapeutics, Inc.
Birmingham, AL · +19 more sites
RecruitingPhase 3NCT07845500
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Sponsor: Pfizer
Birmingham, AL · +15 more sites
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Anniston, AL · Birmingham, AL · +41 more sites
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Birmingham, AL · Dothan, AL · +54 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Anniston, AL · Birmingham, AL · Pelham, AL · +77 more sites
RecruitingNot applicableNCT05216042
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 3NCT07533175
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Birmingham, AL · +14 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Birmingham, AL · Pelham, AL · +97 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Birmingham, AL · Dothan, AL · Fairhope, AL · +118 more sites
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Birmingham, AL · Huntsville, AL · +82 more sites
RecruitingPhase 3NCT07654361
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Birmingham, AL · +69 more sites
RecruitingNot applicableNCT06491537
Time-restricted Eating for Postpartum Weight Loss
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 2 / Phase 3NCT04971720
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingNot applicableNCT06736028
Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 3NCT06760546
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Sponsor: Rhythm Pharmaceuticals, Inc.
Birmingham, AL · +7 more sites
RecruitingNot applicableNCT07220213
FELLAShip to Better Health
Sponsor: University of Alabama at Birmingham
Birmingham, AL
Not yet recruitingPhase 3NCT07850050
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Sponsor: Boehringer Ingelheim
Birmingham, AL · +12 more sites
Not yet recruitingNot applicableNCT07446907
Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood
Sponsor: University of Alabama at Birmingham
Birmingham, AL
Not yet recruitingPhase 2NCT06320951
VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
Sponsor: University of Alabama at Birmingham
Birmingham, AL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.